Compound reveals new link between signaling protein and cell migrationSeptember 26, 2005University of Illinois at Chicago researchers report that a protein that regulates key signaling pathways in cells also plays a role in controlling the active movement or migration of cells. The finding may suggest new pharmaceutical therapies for treating a variety of diseases, including cancer. The protein, known as Raf Kinase Inhibitor Protein, or RKIP, controls activity of kinases, a type of enzyme that acts as a key component in the biochemical signaling pathways responsible for determining almost all cellular activity. But RKIP's own activity is inhibited when a small molecule organic compound called locostatin, discovered earlier by UIC researchers, binds to it. Lead investigator Gabriel Fenteany, assistant professor of chemistry at UIC, reports the finding in the Sept. 26 issue of the journal Chemistry and Biology. The researchers used an approach sometimes called "forward chemical genetics" whereby they first identified locostatin as an inhibitor of cell migration, then used locostatin itself as a kind of bait to fish out the protein to which it binds. That protein was RKIP. "We have implicated this protein in controlling cell migration, a role it was not previously known to play," said Fenteany. "It's a molecular target of locostatin. We found this on the basis of the chemical affinity of locostatin for this protein." As a regulatory protein, RKIP controls the functions of kinases, thereby governing signaling pathways. When these pathways are not properly controlled, all kinds of diseases can result, including cancer. Fenteany and his team also confirmed that RKIP is involved in cell migration by using other methods. "After finding that locostatin targets RKIP, we wanted to verify that RKIP really does control cell migration," Fenteany said. The researchers removed, or knocked down, RKIP in the cell using a method called RNA interference and looked at the effect on cell migration. They did the opposite manipulation as well - artificially increasing the amount of RKIP in the cell and again looking at the effect on cell migration. In each case, the result was consistent with RKIP having an important, positive role in the control of cell migration. "The interest in RKIP now is that it is a new and apparently important modulator of cell migration and therefore a possible target in anti-cancer strategies focused on limiting tumor angiogenesis and metastasis," Fenteany said. More investigation on how exactly RKIP controls cell migration is needed, Fenteany said. UIC researchers are also trying to determine the potential of locostatin as a drug by looking at its effects on different types of cells and tissues. University of Illinois at Chicago |
|||||||||||||||||||||
| Related Cell Migration Current Events and Cell Migration News Articles Alternatively spliced tissue factor identified as promising new biomarker for aggressive cancers A recently discovered form of the protein that triggers blood clotting may play a key role in the molecular mechanisms leading to the growth of certain metastatic cancers, according to new research reported by an international team of scientists. Reactive Oxygen's Role in Metastasis Researchers at the Burnham Institute for Medical Research (Burnham) have discovered that reactive oxygen species, such as superoxide and hydrogen peroxide, play a key role in forming invadopodia, cellular protrusions implicated in cancer cell migration and tumor metastasis. NIH researchers identify key factor that stimulates brain cancer cells to spread Researchers funded by the National Institutes of Health have found that the activity of a protein in brain cells helps stimulate the spread of an aggressive brain cancer called glioblastoma multiforme (GBM). A genetic basis for schizophrenia Schizophrenia is a severely debilitating psychiatric disease that is thought to have its roots in the development of the nervous system; however, major breakthroughs linking its genetics to diagnosis, prognosis and treatment are still unrealized. Carbohydrate acts as tumor suppressor Scientists at Burnham Institute for Medical Research (Burnham) have discovered that specialized complex sugar molecules (glycans) that anchor cells into place act as tumor suppressors in breast and prostate cancers. Scientists identify gene vital to early embryonic cells forming a normal heart and skull New research from Cincinnati Children's Hospital Medical Center highlights the critical role a certain gene and its protein play during early embryonic development on formation of a normal heart and skull. LSUHSC research describes function of key protein in cancer spread Research led by David Worthylake, PhD, Assistant Professor of Biochemistry and Molecular Biology at LSU Health Sciences Center New Orleans, may help lay the groundwork for the development of a compound to prevent the spread of cancer. Tumor growth and chemo response may be predicted by mathematical model The aggressiveness of tumors and their susceptibility to chemotherapy may become easier to predict based on a mathematical model developed at The University of Texas Health Science Center at Houston. NASA's electronic nose may provide neurosurgeons with a new weapon against brain cancer An unlikely multidisciplinary scientific collaboration has discovered that an electronic nose developed for air quality monitoring on Space Shuttle Endeavour can also be used to detect odour differences in normal and cancerous brain cells. Scientists show how a neuron gets its shape Ask a simple question, get a simple answer: When Abraham Lincoln was asked how long a man's legs should be, he absurdly replied, "Long enough to reach the ground." Now, by using a new microscopy technique to watch the growth of individual neurons in the microscopic roundworm Caenorhabditis elegans, Rockefeller University researchers are turning another deceptively simple question on its head. More Cell Migration Current Events and Cell Migration News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||